Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Tectonic Therapeutic, Inc. Director's Dealing 2019

Jan 9, 2019

33251_dirs_2019-01-09_d337b872-fe96-4c64-ae47-c20bfcf01610.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2019-01-07

Reporting Person: Vickers Philip J. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-01-07 Stock Option (Right to Buy) $15.78 A 18743 Acquired 2029-01-06 Common Stock (18743) Direct

Footnotes

F1: The shares vest in 36 equal monthly installments over a three year period following January 7, 2019.